Clinical Trial Update: Early Beta Blocker Administration in STEMI Patients With SCAI B Status [NA]

View source ↗

Summary

A clinical trial evaluating early beta-blocker administration in ST-segment Elevation Myocardial Infarction patients with SCAI B status is currently recruiting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Beta blocker (early administration) (beta-adrenergic blocker)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: ST Segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock Post Myocardial Infarction | NA | Status: RECRUITING